# Relates to capping cost sharing for antiviral COVID-19 therapeutics

**Bill ID:** S8367B
**Session:** 2024
**Sponsor:** Brad Hoylman-Sigal
**Status:** In Assembly Committee
**PDF:** [S8367B PDF](https://legislation.nysenate.gov/pdf/bills/2024/S8367B)

## Summary

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  8367
 
  I N  S E N A T E
 
  January 23, 2024
  ___________
 
 Introduced  by Sen. HOYLMAN-SIGAL -- read twice and ordered printed, and
  when printed to be committed to the Committee on Insurance
 
 AN ACT to amend the insurance  law  and  the  social  services  law,  in
  relation to capping cost sharing for oral antiviral COVID-19 therapeu-
  tics
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1.  Subsection (i) of section 3216 of  the  insurance  law  is
 amended by adding a new paragraph 39 to read as follows:
  (39)  (A)  EVERY  POLICY THAT PROVIDES COVERAGE FOR PRESCRIPTION DRUGS
 SHALL PROVIDE COVERAGE FOR ORAL ANTIVIRAL THERAPEUTICS APPROVED  BY  THE
 FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF COVID-19.
  (B)  THE  COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF THIS PARA-
 GRAPH SHALL NOT BE SUBJECT TO ANNUAL DEDUCTIBLES OR COINSURANCE.
  ยง 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 23 to read as follows:
  (23) (A) EVERY POLICY THAT PROVIDES COVERAGE  FOR  PRESCRIPTION  DRUGS
 SHALL  PROVIDE  COVERAGE FOR ORAL ANTIVIRAL THERAPEUTICS APPROVED BY THE
 FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF COVID-19.
  (B) THE COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF  THIS  PARA-
 GRAPH SHALL NOT BE SUBJECT TO ANNUAL DEDUCTIBLES OR COINSURANCE.
  ยง  3.  Section  4303  of  the insurance law is amended by adding a new
 subsection (vv) to read as follows:
  (VV) (1) EVERY CONTRACT ISSUED BY A MEDICAL EXPENSE  INDEMNITY  CORPO-
 RATION,  A  HOSPITAL SERVICE CORPORATION OR A HEALTH SERVICE CORPORATION
 FOR DELIVERY IN THIS STATE THAT PROVIDES MEDICAL, MAJOR MEDICAL OR SIMI-
 LAR COMPREHENSIVE-TYPE COVERAGE AND PROVIDES COVERAGE  FOR  PRESCRIPTION
 DRUGS  SHALL PROVIDE COVERAGE FOR PRESCRIBED ORAL ANTIVIRAL THERAPEUTICS
 APPROVED BY THE FOOD  AND  DRUG  ADMINISTRATION  FOR  THE  TREATMENT  OF
 COVID-19.
  (2)  SUCH  COVERAGE  REQUIRED  PURSUANT  TO  PARAGRAPH  ONE  OF  THIS
 SUBSECTION SHALL NOT BE SUBJECT TO ANNUAL DEDUCTIBLES OR COINSURANCE.
  ยง 4. Subdivision 2 of section 365-a of  the  social  services  law  is
 amended by adding a new paragraph (nn) to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD14144-01-4
 S. 8367  2
 
  (NN)  PRESCRIBED  ORAL ANTIVIRAL THERAPEUTICS APPROVED BY THE FOOD AND
 DRUG ADMINISTRATION FOR THE TREATMENT  OF  COVID-19.  COVERAGE  REQUIRED
 PURSUANT TO THIS PARAGRAPH SHALL BE PROVIDED AT NO COST TO THE INSURED.
  ยง  5.  This  act  shall take effect immediately and shall apply to any
 policy or contract issued, renewed, modified, altered, or amended on  or
 after January 1, 2025.